What is the fair value of Ingevity Corp (NYSE-NGVT) stock?

The current fair value estimate for Ingevity Corp (NYSE-NGVT) is $55.83. This implies an estimated downside of 21.7% versus the current market price.

Is Ingevity Corp (NYSE-NGVT) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 21.7% versus the current market price.

What is the analyst price target for NYSE-NGVT stock?

The available analyst price target for Ingevity Corp (NYSE-NGVT) is $89. The analyst target implies estimated upside of 24.9%.

How is the financial health of Ingevity Corp?

The current financial health read for Ingevity Corp (NYSE-NGVT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Ingevity Corp's next earnings date?

The next earnings date currently listed for Ingevity Corp (NYSE-NGVT) is November 4, 2026.

Does Ingevity Corp (NYSE-NGVT) pay dividends?

The latest available data indicates no current dividend yield for Ingevity Corp (NYSE-NGVT).

What is the P/E ratio for Ingevity Corp (NYSE-NGVT)?

The current P/E ratio listed for Ingevity Corp (NYSE-NGVT) is 97.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Ingevity Corp?

The current market capitalization listed for Ingevity Corp is 2.45 B.

What is the enterprise value of Ingevity Corp?

The current enterprise value listed for Ingevity Corp is 3.506 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Ingevity Corp?

The ticker symbol for Ingevity Corp is NYSE-NGVT, and the stock is listed on NYSE.

Where is Ingevity Corp (NYSE-NGVT) listed?

Ingevity Corp (NYSE-NGVT) is listed on NYSE.

What is the debt-to-total-capital ratio for Ingevity Corp?

The current debt-to-total-capital ratio listed for Ingevity Corp is 34.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Ingevity Corp?

The free float listed for Ingevity Corp is 99.1%. Free float helps investors understand how much of the share base is available for public trading.

Ingevity Corp (NGVT) Fair Value & Stock Analysis

Ingevity Corp (NGVT)

Ingevity Corp. is a common stock listing on the NYSE representing a materials company focused on specialty chemicals and performance materials. Through its three business segments—Performance Materials, Performance Chemicals, and Advanced Polymer Technologies—it manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers across North America, Asia Pacific, Europe, the Middle East, Africa, and South America.

Its Performance Materials segment supplies hardwood-based and chemically activated carbon products used in gasoline vapor emission control systems and in purification applications for food, water, beverages, and chemicals. Performance Chemicals includes road technologies and industrial specialties used in pavement-related applications, road markings, agrochemical dispersants, lubricants, adhesives, rubber, and other industrial uses. Advanced Polymer Technologies produces caprolactone and caprolactone-based specialty polymers for coatings, resins, elastomers, adhesives, bioplastics, and medical devices.

The company was founded in 1964 and is headquartered in North Charleston, South Carolina. It was formerly known as WestRock Company, Specialty Chemicals Business, and adopted the Ingevity name in September 2015.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
NYSE-NGVT	$55.83	-21.7% Downside	Overvalued	$89	24.9% Upside	Undervalued	Good	0.0%	November 4, 2026	97.2x	52.2x	2.1x	2.45 B	3.506 B	34.3%	99.1%	3.1	614.7%